[1] Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Japanese Journal of Clinical Oncology. 2015; 45: 884–891.
[2] Hoffman MS, DeCesare SL, Roberts WS, Fiorica JV, Finan MA, Cavanagh D. Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. American Journal of Obstetrics and Gynecology. 1992; 166: 30–33.
[3] Abe A, Matoda M, Okamoto S, Kondo E, Kato K, Omatsu K, et al. Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy. World Journal of Surgical Oncology. 2015; 13: 137.
[4] Ang C, Bryant A, Barton DP, Pomel C, Naik R. Exenterative surgery for recurrent gynaecological malignancies. Cochrane Database of Systematic Reviews. 2014; 2014: CD010449.
[5] Benedetti Panici P, Manci N, Bellati F, Di Donato V, Marchetti C, De Falco C, et al. Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence. International Journal of Gynecologic Cancer. 2009; 19: 1625–1631.
[6] Kanao H, Matsuo K, Aoki Y, Tanigawa T, Nomura H, Okamoto S, et al. Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer. Journal of gynecologic Oncology. 2019; 30: e71.
[7] Dodge JA, Eltabbakh GH, Mount SL, Walker RP, Morgan A. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecologic Oncology. 2001; 83: 363– 369.
[8] Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G. Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. International Journal of Gynecological Cancer. 1993; 3: 193–198.
[9] Höckel M. Long-term experience with (laterally) extended endopelvic resection (LEER) in relapsed pelvic malignancies. Current Oncology Reports. 2015; 17: 435.
[10] Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecologic Oncology. 2005; 99: 153–159.
[11] Choi Y, Hur S, Park J, Lee K. Laparoscopic upper vaginectomy for post-hysterectomy high risk vaginal intraepithelial neoplasia and superficially invasive vaginal carcinoma. World Journal of Surgical Oncology. 2013; 11: 126.
[12] Zhao M, Zhang J, Wei G, Hu C, Zhu Z. Feasibility and efficacy of vaginectomy for patients with vaginal vault high-grade squamous intraepithelial lesion after hysterectomy: a retrospective analysis of 52 cases. International Journal of Clinical and Experimental Medicine. 2017; 10: 12223–12228.
[13] Vizzielli G, Chiantera V, Tinelli G, Fagotti A, Gallotta V, Di Giorgio A, et al. Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: does that make sense? A single-institution case-series. European Journal of Surgical Oncology. 2017; 43: 710–716.
[14] Ebina Y, Mikami M, Nagase S, Tabata T, Kaneuchi M, Tashiro H, et al. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer. International Journal of Clinical Oncology. 2019; 24: 1–19.